TB-402

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTB-402
Drug Alias NameMab LE 2E9Anti factor VIII monoclonal antibody LE 2E9TGX Krix-1TB-402
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionCoagulation factor VIII inhibitors
TargetsCoagulation factor VIII
Therapy Area/IndicationsVenous Thromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Leuven
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of LeuvenThrombogenics IncBioinvent International Ab +[4] 
Active IndicationsN/A
Inactive IndicationsVenous Thromboembolism

Other Information

ATC CodeN/A
Related LinksN/A